Category: Regulatory and Drug Development Terminology
Risk-Benefit Assessment
An evaluation of the potential benefits of a treatment in relation to its known and potential risks. In DMD, this assessment considers the seriousness of the disease, available alternatives, evidence of clinical benefit, treatment-related harms, and the needs of the intended patient population.
- Updated November 3, 2026